ALK launches tablet vaccine for tree pollen allergy

The allergy solutions company ALK launches its tablet vaccine for tree pollen allergy in Canada, where more than seven million people suffer from tree pollen allergy. The launch completes ALK's tablet portfolio in Canada, where the expected sales potential is in the high figures.
Photo: ALK / PR
Photo: ALK / PR

Barely half-a-year after the Canadian health authorities approved the allergy company ALK's tablet vaccine for tree pollen allergy, the first vaccines are now available on the market in Canada.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading